| RS866316633 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS866329957 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS866333931 |
MAGEL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS866335788 |
MYORG
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS866340497 |
CYP7B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Hereditary spastic paraplegia |
| RS866345446 |
TANC2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS866348422 |
INF2
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 5, Focal segmental glomerulosclerosis 5 |
| RS866352637 |
MYO7A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 1B, Usher syndrome |
| RS866364527 |
ACAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS866367185 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS866370455 |
ASH1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 52 |
| RS866373727 |
DPYSL5
|
Health Risk |
Pathogenic |
Ritscher-Schinzel syndrome 4, DPYSL5-related disorder |
| RS866374385 |
ERCC6
|
Health Risk |
Pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS866379139 |
ERCC3
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum group B, Xeroderma pigmentosum group B |
| RS866380588 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS866386973 |
SNTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, SNTA1-related disorder |
| RS866388216 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, ACADM-related disorder |
| RS866392702 |
ALDH3A2
|
Health Risk |
Pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS866395428 |
LCA5
|
Health Risk |
Pathogenic |
Retinal dystrophy, Leber congenital amaurosis |
| RS866395974 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS866399151 |
MOCS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Intellectual disability |
| RS866400911 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS866402530 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS866403196 |
DGUOK
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) |
| RS866407525 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS866415691 |
KMT2B
|
Health Risk |
Likely pathogenic |
— |
| RS866419580 |
MAGEL2
|
Health Risk |
Pathogenic |
Schaaf-Yang syndrome, Schaaf-Yang syndrome |
| RS866424446 |
ACADVL
|
Health Risk |
Conflicting classifications of pathogenicity |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS866426234 |
PBX1
|
Health Risk |
Pathogenic |
— |
| RS866429868 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Hypophosphatemic rickets |
| RS866430018 |
CYP11B1
|
Health Risk |
Pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS866430850 |
EP300
|
Health Risk |
Pathogenic |
— |
| RS866431185 |
FIG4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS866434305 |
CHD8
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS866435331 |
CDH23
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Usher syndrome type 1D |
| RS866435487 |
EPG5
|
Health Risk |
Pathogenic/Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS866435648 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS866445127 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS866464446 |
ACADVL
|
Health Risk |
Conflicting classifications of pathogenicity |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS866467799 |
ZNF292
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS866468317 |
MYSM1
|
Health Risk |
Pathogenic |
Bone marrow failure syndrome 4, Bone marrow failure syndrome 4 |
| RS866469235 |
PRKCSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic liver disease 1, Inborn genetic diseases |
| RS866472917 |
PKLR
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS866475029 |
ZNF292
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder, autosomal dominant 64 |
| RS866476223 |
OTOG
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 18B, Autosomal recessive nonsyndromic hearing loss 18B |
| RS866477353 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS866479368 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS866487633 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS866493167 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS866494171 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS866494435 |
SZT2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS866495683 |
SCNN1G
|
Health Risk |
Pathogenic |
Bronchiectasis with or without elevated sweat chloride 3, Bronchiectasis with or without elevated sweat chloride 3 |
| RS866500582 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS866502805 |
COL2A1
|
Health Risk |
Pathogenic |
COL2A1-related disorder, COL2A1-related disorder |
| RS866504799 |
TGFB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS866504928 |
CAVIN1
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 4, Congenital generalized lipodystrophy type 4 |
| RS866511152 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS866512456 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS866518214 |
SYNPO
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS866520787 |
LRP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS866521873 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS866524368 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS866525850 |
KDM5B
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS866536893 |
WDFY3
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly 18, primary |
| RS866539724 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS866543181 |
PCARE
|
Health Risk |
Pathogenic |
Retinal dystrophy, Autosomal recessive retinitis pigmentosa |
| RS866548835 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer, Hereditary cancer-predisposing syndrome |
| RS866551482 |
WDR73
|
Health Risk |
Likely pathogenic |
Galloway-Mowat syndrome 1, Galloway-Mowat syndrome 1 |
| RS866558712 |
MANBA
|
Health Risk |
Pathogenic |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS866566089 |
SELENON
|
Health Risk |
Conflicting classifications of pathogenicity |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS866575708 |
TERT
|
Health Risk |
Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS866578354 |
ALG8
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant polycystic liver disease, ALG8 congenital disorder of glycosylation |
| RS866581841 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 6 |
| RS866589638 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS866592729 |
BRWD3
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 93 |
| RS866595552 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS866595729 |
MCPH1
|
Health Risk |
Likely pathogenic |
— |
| RS866599436 |
ALAS2
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked sideroblastic anemia 1, X-linked sideroblastic anemia 1 |
| RS866604005 |
MFN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2A2 |
| RS866604517 |
GFM1
|
Health Risk |
Pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS866606166 |
LRP5
|
Health Risk |
Likely pathogenic |
6 conditions, 6 conditions |
| RS866608532 |
ADGRG1
|
Health Risk |
Likely pathogenic |
Polymicrogyria, bilateral perisylvian |
| RS866612394 |
POT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS866622752 |
PRKAR1B
|
Health Risk |
Likely pathogenic |
Marbach-Schaaf neurodevelopmental syndrome, Marbach-Schaaf neurodevelopmental syndrome |
| RS866625610 |
AMT
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 2 |
| RS866629962 |
UNC13D
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, UNC13D-related disorder |
| RS866630296 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS866632178 |
POGZ
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS866636096 |
GRIN2B
|
Health Risk |
Pathogenic |
Developmental disorder, Developmental disorder |
| RS866637461 |
RTEL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS866641122 |
LEPR
|
Health Risk |
Likely pathogenic |
Obesity due to congenital leptin deficiency, Obesity due to congenital leptin deficiency |
| RS866649101 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS866656179 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS866656949 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS866658624 |
UNC80
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS866662905 |
AARS1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Inborn genetic diseases |
| RS866663584 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS866677740 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS866679165 |
SOX9
|
Health Risk |
Conflicting classifications of pathogenicity |
Camptomelic dysplasia, Inborn genetic diseases |
| RS866681472 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |